Retatrutide Auto-Inject Pen – For Research Purposes Only
Retatrutide Auto-Inject Pen – For Research Purposes Only
Triple Agonist (GLP-1/GIP/Glucagon) — Auto-Inject Pen
Retatrutide represents the next frontier in metabolic research. As the world's first triple hormone receptor agonist, it simultaneously targets GLP-1, GIP, and glucagon receptors — offering a three-pronged approach to metabolic research that goes beyond current dual-agonist compounds.
This innovative research compound has generated significant scientific interest due to its unique mechanism of action, with early studies suggesting enhanced efficacy compared to existing dual-receptor agonists.
Available Dosages
📊 Research Highlights
Phase 2 trials demonstrated up to 24.2% body weight reduction over 48 weeks — potentially the most effective weight management compound studied to date. The triple-agonist mechanism also showed improvements in metabolic markers beyond weight loss alone.
⚠️ Research Use Only: This product is strictly for research purposes and is NOT intended for human consumption. Not for diagnosis, treatment, cure, or prevention of any disease. Must be 18+ to purchase.
🚚 Shipping
UK Mainland: £7.50 — Royal Mail Next Day Delivery
Ireland & Northern Ireland: £10.50 — Royal Mail Next Day Delivery
